Objective: To investigate the effect of passive dilatation (PD) on ureteral stricture (US) rates after retrograde intrarenal surgery (RIRS), and to determine the factors that predict US. Material and Methods: Patients who underwent RIRS (Group 1) and patients who could undergo RIRS after PD (Group 2) were compared in terms of demographic data, clinical characteristics, perioperative and postoperative complications. The primary end point was US rate at postoperative 1 year. The predictive factors for US was assessed with logistic regression analysis. Results: US was determined in 12 (4.61%) and in 1 (0.67%) patients for Group 1 and 2, respectively. When the study population was grouped according to the US, the rate of PD was observed to be lower (p=0.037), and stone volume, surgical duration were observed to be higher in the US group, statistically (p<0.001 and p=0.034 respectively). The rate of PD, Stone volume and surgical duration were detected as predictive factors for US. The cut-off value of stone volume for US was 2,408 mm3 in receiver- operating characteristic curve analysis. Above the cut-off value, it was observed that the surgical duration was higher in cases with US, and there was no difference between the groups in terms of PD statistically. Conclusion: We conclude that PD is protective against US. However it was observed that PD was not protective in patients with stone volume higher than the cut off value, and the most important risk factor for US was found to be prolonged surgical duration.
Keywords: Retrograde intrarenal surgery; passive dilatation; ureteral stent; ureteral stricture
Amaç: Bu çalışmanın amacı, böbrek taşı tedavisi için retrograd intrarenal cerrahi (RİRC) yapılan hastalarda pasif dilatasyonun (PD) üreteral darlık (ÜD) insidansına olan etkisini ve ÜD gelişimini predikte eden faktörleri araştırmaktır. Gereç ve Yöntemler: PD uygulamaya gerek kalmadan RİRC uygulanan hastalar (Grup 1) ile PD sonrası RİRC uygulanabilen hastalar (Grup 2); demografik veriler, klinik özellikler, perioperatif ve postoperatif komplikasyonlar açısından karşılaştırıldı. Çalışmanın birincil sonlanım noktası, postop 1. yıl ÜD saptanma oranı olarak belirlendi. ÜD gelişimini predikte eden faktörler lojistik regresyon analizi kullanılarak belirlendi. Bulgular: ÜD 1. grupta 12 (%4,61) hastada, 2. grupta 1 (%0,67) hastada saptanmıştır. Çalışma popülasyonu, ÜD gelişimi açısından gruplandırıldığında ise ÜD grubunda PD oranı daha düşük (p=0,037), ortalama taş hacmi ve cerrahi süresi daha yüksek saptandı (p<0,001 ve p=0,034). PD, taş hacmi ve cerrahi süre ÜD için prediktif faktörler olarak saptandı. ÜD gelişimi için taş volümü kestirim değeri alıcı işletim karakteristiği eğrisi analizinde 2.408 mm3 olarak saptandı. Taş volümü saptanan kestirim değerinin üzerinde olan olgularda yapılan analizde, operasyon süresinin ÜD gelişen olgularda daha yüksek olduğu, PD açısından gruplar arasında fark olmadığı izlenmiştir. Sonuç: PD'nin ÜD gelişimi açısından koruyucu bir faktör olabileceği sonucuna varılmıştır. Bununla birlikte, yüksek taş hacmine sahip hastalarda, PD'nin koruyucu bir faktör olmadığı görülmüş, en önemli risk faktörünün uzamış operasyon süresi olduğu saptanmıştır.
Anahtar Kelimeler: Retrograd intrarenal cerrahi; pasif dilatasyon; üreteral stent; üreteral darlık
- el-Reshaid K, Mughal H, Kapoor M. Epidemiological profile, mineral metabolic pattern and crystallographic analysis of urolithiasis in Kuwait. Eur J Epidemiol. 1997;13(2):229-34. [Crossref] [PubMed]
- Smith LH. The medical aspects of urolithiasis: an overview. J Urol. 1989;141(3 Pt 2):707-10. [Crossref] [PubMed]
- Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2016;69(3):475-82. [Crossref] [PubMed]
- Al-Qahtani SM, Gil-Deiz-de-Medina S, Traxer O. Predictors of clinical outcomes of flexible ureterorenoscopy with holmium laser for renal stone greater than 2 cm. Adv Urol. 2012;2012:543537. [Crossref] [PubMed] [PMC]
- Breda A, Ogunyemi O, Leppert JT, Lam JS, Schulam PG. Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater--is this the new frontier? J Urol. 2008;179(3):981-4. [Crossref] [PubMed]
- de la Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M, et al; CROES URS Study Group. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014;28(2):131-9. [Crossref] [PubMed]
- Cetti RJ, Biers S, Keoghane SR. The difficult ureter: what is the incidence of pre-stenting? Ann R Coll Surg Engl. 2011;93(1):31-3. [Crossref] [PubMed] [PMC]
- Stoller ML, Wolf JS Jr, Hofmann R, Marc B. Ureteroscopy without routine balloon dilation: an outcome assessment. J Urol. 1992;147(5):1238-42. [Crossref] [PubMed]
- Ji C, Gan W, Guo H, Lian H, Zhang S, Yang R, et al. A prospective trial on ureteral stenting combined with secondary ureteroscopy after an initial failed procedure. Urol Res. 2012;40(5):593-8. [Crossref] [PubMed]
- Ambani SN, Faerber GJ, Roberts WW, Hollingsworth JM, Wolf JS Jr. Ureteral stents for impassable ureteroscopy. J Endourol. 2013;27(5):549-53. [Crossref] [PubMed]
- Wenzler DL, Kim SP, Rosevear HM, Faerber GJ, Roberts WW, Wolf JS Jr. Success of ureteral stents for intrinsic ureteral obstruction. J Endourol. 2008;22(2):295-9. [Crossref] [PubMed]
- Pardalidis NP, Papatsoris AG, Kapotis CG, Kosmaoglou EV. Treatment of impacted lower third ureteral stones with the use of the ureteral access sheath. Urol Res. 2006;34(3):211-4. [Crossref] [PubMed]
- Natalin RA, Hruby GW, Okhunov Z, Singh H, Phillips CK, Humphrey PA, et al. Pilot study evaluating ureteric physiological changes with a novel 'ribbon stent' design using electromyographic and giant magnetoresistive sensors. BJU Int. 2009;103(8):1128-31. [Crossref] [PubMed]
- Patel U, Kellett MJ. Ureteric drainage and peristalsis after stenting studied using colour Doppler ultrasound. Br J Urol. 1996;77(4):530-5. [Crossref] [PubMed]
- Venkatesh R, Landman J, Minor SD, Lee DI, Rehman J, Vanlangendonck R, et al. Impact of a double-pigtail stent on ureteral peristalsis in the porcine model: initial studies using a novel implantable magnetic sensor. J Endourol. 2005;19(2):170-6. [Crossref] [PubMed]
- Schoenthaler M, Wilhelm K, Kuehhas FE, Farin E, Bach C, Buchholz N, et al. Postureteroscopic lesion scale: a new management modified organ injury scale--evaluation in 435 ureteroscopic patients. J Endourol. 2012;26(11):1425-30. [Crossref] [PubMed]
- Burks FN, Santucci RA. Management of iatrogenic ureteral injury. Ther Adv Urol. 2014;6(3):115-24. [Crossref] [PubMed] [PMC]
- Elliott SP, McAninch JW. Ureteral injuries: external and iatrogenic. Urol Clin North Am. 2006;33(1):55-66, vi. [Crossref] [PubMed]
- de la Rosette JJ, Skrekas T, Segura JW. Handling and prevention of complications in stone basketing. Eur Urol. 2006;50(5):991-8; discussion 998-9. [Crossref] [PubMed]
- Mogilevkin Y, Sofer M, Margel D, Greenstein A, Lifshitz D. Predicting an effective ureteral access sheath insertion: a bicenter prospective study. J Endourol. 2014;28(12):1414-7. [Crossref] [PubMed]
- Zelenko N, Coll D, Rosenfeld AT, Smith RC. Normal ureter size on unenhanced helical CT. AJR Am J Roentgenol. 2004;182(4):1039-41. [Crossref] [PubMed]
- Bourdoumis A, Tanabalan C, Goyal A, Kachrilas S, Buchholz N, Masood J. The difficult ureter: stent and come back or balloon dilate and proceed with ureteroscopy? What does the evidence say? Urology. 2014;83(1):1-3. [Crossref] [PubMed]
- Geavlete P, Georgescu D, Niţă G, Mirciulescu V, Cauni V. Complications of 2735 retrograde semirigid ureteroscopy procedures: a single-center experience. J Endourol. 2006;20(3):179-85. [Crossref] [PubMed]
- Dessyn JF, Balssa L, Chabannes E, Jacquemet B, Bernardini S, Bittard H, et al. Flexible ureterorenoscopy for renal and proximal ureteral stone in patients with previous ureteral stenting: impact on stone-free rate and morbidity. J Endourol. 2016;30(10):1084-8. [Crossref] [PubMed]
- Hubert KC, Palmer JS. Passive dilation by ureteral stenting before ureteroscopy: eliminating the need for active dilation. J Urol. 2005;174(3):1079-80; discussion 1080. [Crossref] [PubMed]
- Jessen JP, Breda A, Brehmer M, Liatsikos EN, Millan Rodriguez F, Osther PJ, et al. International Collaboration in Endourology: multicenter evaluation of prestenting for ureterorenoscopy. J Endourol. 2016;30(3):268-73. [Crossref] [PubMed]
- Delvecchio FC, Auge BK, Brizuela RM, Weizer AZ, Silverstein AD, Lallas CD, et al. Assessment of stricture formation with the ureteral access sheath. Urology. 2003;61(3):518-22; discussion 522. [Crossref] [PubMed]
- Stern KL, Loftus CJ, Doizi S, Traxer O, Monga M. A prospective study analyzing the association between high-grade ureteral access sheath injuries and the formation of ureteral strictures. Urology. 2019;128:38-41. [Crossref] [PubMed]
- Traxer O, Thomas A. Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery. J Urol. 2013;189(2):580-4. [Crossref] [PubMed]
- Lallas CD, Auge BK, Raj GV, Santa-Cruz R, Madden JF, Preminger GM. Laser Doppler flowmetric determination of ureteral blood flow after ureteral access sheath placement. J Endourol. 2002;16(8):583-90. [Crossref] [PubMed]
- Özsoy M, Kyriazis I, Vrettos T, Kotsiris D, Ntasiotis P, Seitz C, et al. Histological changes caused by the prolonged placement of ureteral access sheaths: an experimental study in porcine model. Urolithiasis. 2018;46(4):397-404. [Crossref] [PubMed]
- Sorokin I, Cardona-Grau DK, Rehfuss A, Birney A, Stavrakis C, Leinwand G, et al. Stone volume is best predictor of operative time required in retrograde intrarenal surgery for renal calculi: implications for surgical planning and quality improvement. Urolithiasis. 2016;44(6):545-50. [Crossref] [PubMed]
- Whitehurst L, Pietropaolo A, Geraghty R, Kyriakides R, Somani BK. Factors affecting operative time during ureteroscopy and stone treatment and its effect on outcomes: retrospective results over 6.5 years. Ther Adv Urol. 2020;12:1756287220934403. [Crossref] [PubMed] [PMC]
.: Process List